Village Farms International (VFF) Corporate presentation summary

Investment profile

• 7.2M ft² of greenhouse and indoor cultivation assets globally; cannabis utilization ~30%.

• 37 years of controlled-environment agriculture experience, applied to global cannabinoid opportunities.

• Investment themes include EU-GMP certification, cost efficiency, international growth, U.S. market optionality and shareholder-aligned management.

Transaction and profitability

• In May 2025, 80 acres of Texas greenhouse assets were sold for $40M cash and a 37.9% equity stake in Verdexa Holdings, privatizing most of the legacy produce business.

• Cumulative net income from continuing operations reached $33.0M since the Verdexa transaction closed.

Operating scale and cost advantages

• Delta, BC has 4.8M ft² across three facilities; recent upgrades made Delta the world's largest EU-GMP-certified cannabis facility.

• Delta 2 has 875,000 ft² in cannabis production; conversion of the remaining 275,000 ft² is underway, targeting ~80,000 kg of annual dried-flower output, excluding trim.

• Delta 3 has 1.1M ft² of full cannabis production capacity, targeting ~80,000 kg of annual dried flower, excluding trim; site also includes processing and tissue-culture facilities.

• EU-GMP compliance is positioned as a quality and customer advantage in European medical markets; scale and operational execution support industry-leading production costs.